GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea.
Cliona O'DonnellOdhrán RyanAndrew E HoganDesmond KillickShane CrillyJonathan D DoddDavid J MurphySilke RyanDonal O'SheaPublished in: Obesity (Silver Spring, Md.) (2024)
These data support the hypothesis that upregulation of VAT metabolic activity by GLP-1 contributes to its weight loss action in humans, and this subject warrants further detailed investigation.
Keyphrases
- adipose tissue
- obstructive sleep apnea
- weight loss
- insulin resistance
- bariatric surgery
- cell proliferation
- electronic health record
- poor prognosis
- signaling pathway
- positive airway pressure
- big data
- body mass index
- long non coding rna
- bone marrow
- machine learning
- artificial intelligence
- deep learning
- cell therapy
- weight gain